Concomitant anticoagulants and the survival of cancer patients treated with immune checkpoint inhibitors: a meta-analysis
Abstract Anticoagulants were suggested to influence cancer survival by possible immunomodulatory effect. However, it remained unclear if concomitant use of anticoagulants and various types of them could influence the efficacy of immune checkpoint inhibitors (ICIs) in cancer patients. Accordingly, th...
Saved in:
| Main Authors: | Jin Xiong, Hongmei Jian, Zhenzhou Yang, Lei Xia |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-16236-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anticoagulants: dose control methods and inhibitors
by: V. O. Bitsadze, et al.
Published: (2022-05-01) -
POSSIBILITIES OF INHIBITING ANTICOAGULANT ACTIVITIES THAT INHIBIT XA-FACTOR
by: A. D. Erlich
Published: (2019-06-01) -
Anticoagulant effects of edoxaban in cancer and noncancer patients with venous thromboembolism
by: Masashi Yoshida, et al.
Published: (2025-04-01) -
ERA OF NEW ANTICOAGULANTS IN THE TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION: PROSPECTS AND CHALLENGES
by: Z. M. Safiullina, et al.
Published: (2015-09-01) -
Definition of factor Xa inhibitor–related, life‐threatening gastrointestinal bleeding and guidance on when to use reversal therapy: A Delphi panel
by: Gregory J. Fermann, et al.
Published: (2023-10-01)